封面
市場調查報告書
商品編碼
1446441

臨床實驗室服務市場規模、佔有率、趨勢分析報告:按測試類型、按服務供應商、按應用、按地區、細分市場預測,2024-2030 年

Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry), By Service Provider, By Application, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

臨床實驗室服務市場成長與趨勢:

Grand View Research, Inc.最新報告顯示,到2030年,全球臨床實驗室服務市場規模預計將達到2867.7億美元,2024年至2030年複合年成長率為3.5%。

該行業的成長是由於老年人口的增加,導致對疾病早期診斷的需求增加。糖尿病和心血管疾病(CVD)等目標疾病盛行率的增加是預測期內產業成長的重要動力。心血管疾病是全世界死亡的主要原因。疾病管理方面未滿足的醫療需求以及隨後更多地區患者意識的提高預計將推動對臨床實驗室檢測的需求。

透過突破和漸進式進步來改進臨床實驗室技術是產業成長的高影響力驅動力。市場參與者正在努力推出新服務,以滿足患者未滿足的需求。例如,2022 年 5 月,漢密爾頓縣與 Ethos Laboratories 合作開設了免費的 COVID-19 檢測設施。 2022 年 7 月,梅奧診所實驗室開始檢測猴痘,提高了更廣泛受眾的可用性和可近性。此外,Quest Diagnostics 將於 2022 年 1 月與 eMed 合作,透過 QuestDirect 推出 COVID-19 快速抗原檢測,提供在家中進行 COVID-19 檢測的機會。這場流行病已經影響了全世界數百萬人。根據 CDC 和 WHO 的說法,診斷 COVID-19 的標準是呼吸道樣本的 RT-PCR。

採用 PCR 技術診斷 COVID-19 並對病毒進行測序以開發治療方法正在推動該行業的發展。由於這次大流行,用於診斷新型冠狀病毒的測試的核准增加,其中大多數測試已獲得聯邦機構的緊急使用授權(EUA)核准。此外,該行業透過實驗室和醫院等不同的銷售管道運作。各地區強大參與者的存在預計將推動該行業的發展。例如,2022年2月,Labcorp與Ascension建立全面合作關係。透過此次合作,Labcorp 將為 Ascension 在 10 個州的醫院實驗室提供服務,並為其推廣實驗室營運購買資產。

臨床實驗室服務市場報告亮點

  • 2021年,由於病理分析的需求不斷增加,臨床化學領域將佔據壓倒性佔有率。
  • 由於院內實驗室的增加,預計院內實驗室部分在預測期內將以最快的複合年成長率成長。
  • 由於藥物發現和藥物開發的增加,生物分析和實驗室化學服務產業將成為 2023 年最收益的產業。
  • 由於引入創新服務來滿足不斷成長的需求,該行業正在經歷前所未有的成長。
  • 由於製造設施的改善和慢性病的增加,預計亞太地區在預測期內將呈現最快的複合年成長率。

目錄

第1章臨床實驗室服務市場:調查方法與範圍

第2章臨床實驗室服務市場:執行摘要

  • 臨床實驗室服務市場:市場前景

第3章臨床實驗室服務市場:產業展望

  • 市場體系展望
  • 普及和成長前景圖
  • 市場動態
  • 依因素(政治/法律、經濟/技術)進行 SWOT 分析
  • 產業分析-波特五力分析
  • 贖回和監管場景
  • 主要交易和戰略聯盟

第4章臨床實驗室服務市場:測試類型的估計和趨勢分析

  • 2023 年和 2030 年測試類型市場佔有率
  • 細分儀表板
  • 按測試類型分類的全球臨床實驗室服務市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第5章臨床實驗室服務市場:服務供應商估計與趨勢分析

  • 2023年及2030年服務供應商市場佔有率
  • 細分儀表板
  • 按服務供應商分類的全球臨床實驗室服務市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第6章 臨床檢測服務市場:使用量估算與趨勢分析

  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 按應用分類的全球臨床實驗室服務市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第7章臨床實驗室服務市場:按地區估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測趨勢分析:
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 秘魯
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • LABORATORY CORPORATION OF AMERICA HOLDINGS(LABCORP)
    • QIAGEN NV
    • QUEST DIAGNOSTICS INCORPORATED
    • OPKO HEALTH, INC
    • CHARLES RIVER LABORATORIES
    • ARUP LABORATORIES(ASSOCIATED REGIONAL AND UNIVERSITY PATHOLOGISTS, INC.)
    • SONIC HEALTHCARE
    • NEOGENOMICS LABORATORIES, INC.
    • FRESENIUS MEDICAL CARE AG &CO. KGAA
    • SIEMENS HEALTHCARE LIMITED
    • SYNLAB International GmbH
    • Mayo Clinic Laboratories
    • Unilabs
    • Eurofins Scientific SE
Product Code: 978-1-68038-250-1

Clinical Laboratory Service Market Growth & Trends:

The global clinical laboratory service market size is expected to reach USD 286.77 billion by 2030, registering a CAGR of 3.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the industry can be attributed to the increasing prevalence of the geriatric population, which, in turn, is propelling the demand for early disease diagnosis. The growing prevalence of target diseases, such as diabetes and Cardiovascular Diseases (CVDs), is a high impact-rendering driver for industry growth over the forecast period. Cardiovascular disease is the leading cause of death globally. The presence of unmet medical needs pertaining to disease management and the subsequent increase in patient awareness in more regions are expected to boost the demand for clinical laboratory testing.

Improvements in laboratory testing technology throughbreakthrough and incremental advances are high-impact-rendering drivers for industry growth. Market firms are engaged in introducing new services to serve the unmet demand of patients. For instance, in May 2022, Hamilton County entered into a partnership with Ethos Laboratories for the launch of no-cost COVID-19 testing sites. In July 2022, Mayo Clinic laboratories launched monkeypox tests to increase availability and accessibility to a wider target population. Moreover, in January 2022, Quest Diagnostics launched COVID-19 rapid antigen tests available through QuestDirect in collaboration with eMed to provide access to testing for COVID-19 at home. The pandemic affected millions of people globally. According to the CDC and WHO, the standard for diagnosis of COVID-19 is RT-PCR for samples from the respiratory tract.

The adoption of PCR technology for the diagnosis of COVID-19 and the genetic sequencing of the virus for the development of a cure is driving the industry. Due to this pandemic, there is an increase in the approval of tests for the diagnosis of the novel coronavirus, with most of these tests approved under Emergency Use Authorization (EUA) by federal agencies. Furthermore, the industry operates through different sales channels-laboratories and hospitals. The presence of prominent players in various regions is expected to drive the industry. For instance, in February 2022,Labcorp entered into a comprehensive partnership with Ascension. Through this collaboration, Labcorp will handle Ascension's hospital-based labs situated in ten states for buying assets for its outreach laboratory business.

Clinical Laboratory Service Market Report Highlights:

  • In 2021, the clinical chemistry segment held a dominant share owing to the increasing need for pathology analysis
  • The hospital-based laboratories segment is projected to grow at the fastest CAGR over the forecast period owing to increasing hospital-integrated laboratories
  • The bioanalytical & lab chemistry services segment was the highest revenue-generating segment in 2023 due to the increasing drug discovery and developmen
  • The industry has seen unprecedented growth due to the introduction of innovative services to address the rising demands
  • Asia Pacific is expected to witness the fastest CAGR during the forecast period due to improved manufacturing facilities and an increasing prevalence of chronic disease

Table of Contents

Chapter 1 Clinical Laboratory Services Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
      • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
  • 1.7 Global Market: Cagr Calculation
  • 1.8 Global Market: Cagr Calculation
  • 1.9 List Of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:
  • 1.11 List Of Abbreviations

Chapter 2 Clinical Laboratory Services Market: Executive Summary

  • 2.1 Clinical Laboratory Services Market: Market Outlook
    • 2.1.1 Market Summary

Chapter 3 Clinical Laboratory Services Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Technological Advancements In The Filed Of Clinical Testing
      • 3.3.1.2 Growing Prevalence Of Target Diseases Coupled With Rising Demand For Early Disease Diagnostic Tests
      • 3.3.1.3 Introduction Of Novel Solutions
      • 3.3.1.4 Introduction Of Home Health Tests
      • 3.3.1.5 Outbreak Of Coivd-19 Technologies
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Presence Of Stringent Regulatory Framework
  • 3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4. Clinical Laboratory Services Market: Test Type Estimates & Trend Analysis

  • 4.1. Test Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Laboratory Services Market by Test Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Genetic Testing
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Clinical Chemistry
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Routine Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Therapeutic Drug Monitoring Testing Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Endocrinology Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.5. Specialized Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.6. Other Clinical Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Medical Microbiology Testing
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.2. Infectious Disease Testing Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.3. Transplant Diagnostic Testing Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.4. Other Microbiology Testing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Hematology Testing
    • 4.4.5. Immunology Testing
    • 4.4.6. Cytology Testing
    • 4.4.7. Drug of Abuse Testing
    • 4.4.8. Other Esoteric Tests
      • 4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Laboratory Services Market: Service Provider Estimates & Trend Analysis

  • 5.1. Service Provider Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Laboratory Services Market by Service Provider Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospital-Based Laboratories
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Stand-Alone Laboratories
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Clinic-Based Laboratories
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Laboratory Services Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Clinical Laboratory Services Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Bioanalytical & Lab Chemistry Services
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Toxicology Testing Services
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Cell & Gene Therapy Related Services
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Preclinical & Clinical Trial Related Services
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Drug Discovery & Development Related Services
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Others
      • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Clinical Laboratory Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Colombia
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework/ reimbursement structure
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Peru
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework/ reimbursement structure
      • 7.8.5.3. Competitive scenario
      • 7.8.5.4. Peru market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. QIAGEN NV
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. QUEST DIAGNOSTICS INCORPORATED
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. OPKO HEALTH, INC
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. CHARLES RIVER LABORATORIES
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. ARUP LABORATORIES (ASSOCIATED REGIONAL AND UNIVERSITY PATHOLOGISTS, INC.)
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. SONIC HEALTHCARE
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. NEOGENOMICS LABORATORIES, INC.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. FRESENIUS MEDICAL CARE AG & CO. KGAA
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. SIEMENS HEALTHCARE LIMITED
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. SYNLAB International GmbH
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Mayo Clinic Laboratories
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives
    • 8.3.16. Unilabs
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial performance
      • 8.3.16.3. Product benchmarking
      • 8.3.16.4. Strategic initiatives
    • 8.3.17. Eurofins Scientific SE
      • 8.3.17.1. Company overview
      • 8.3.17.2. Financial performance
      • 8.3.17.3. Product benchmarking
      • 8.3.17.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America clinical laboratory services market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 4 North America clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 5 North America clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 7 U.S. clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 8 U.S. clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 9 Canada clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 10 Canada clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 11 Canada clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 12 Europe clinical laboratory services market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 14 Europe clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 15 Europe clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 16 Germany clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Germany clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 18 Germany clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 19 UK clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 20 UK clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 21 UK clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 22 France clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 23 France clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 24 France clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 25 Italy clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 26 Italy clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 27 Italy clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 28 Spain clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Spain clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 30 Spain clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 31 Denmark clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Denmark clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 33 Denmark clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 34 Sweden clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 35 Sweden clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 36 Sweden clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 37 Norway clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Norway clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 39 Norway clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific clinical laboratory services market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 44 China clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 45 China clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 46 China clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 47 Japan clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 48 Japan clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 49 Japan clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 50 India clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 51 India clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 52 India clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 53 South Korea clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 54 South Korea clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 55 South Korea clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 56 Australia clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 57 Australia clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 58 Australia clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 59 Thailand clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 60 Thailand clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 61 Thailand clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 62 Latin America clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 63 Latin America clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 64 Latin America clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 65 Brazil clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 66 Brazil clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 67 Brazil clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 68 Mexico clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 69 Mexico clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 70 Mexico clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 71 Argentina clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 72 Argentina clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 73 Argentina clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 74 Colombia clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 75 Colombia clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 76 Colombia clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 77 Peru clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 78 Peru clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 79 Peru clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 80 MEA clinical laboratory services market, by region, 2018 - 2030 (USD Million)
  • Table 81 MEA clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 82 MEA clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 83 MEA clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 85 South Africa clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 86 South Africa clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 91 UAE clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 92 UAE clinical laboratory services market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
  • Table 95 Kuwait clinical laboratory services market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Clinical laboratory services market: market outlook
  • Fig. 14 Clinical laboratory services competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical laboratory services market driver impact
  • Fig. 20 Clinical laboratory services market restraint impact
  • Fig. 21 Clinical laboratory services market strategic initiatives analysis
  • Fig. 22 Clinical laboratory services market: Test Type movement analysis
  • Fig. 23 Clinical laboratory services market: Test Type outlook and key takeaways
  • Fig. 24 Genetic Testing market estimates and forecast, 2018 - 2030
  • Fig. 25 Clinical chemistry market estimates and forecast, 2018 - 2030
  • Fig. 26 Routine chemistry testing market estimates and forecast, 2018 - 2030
  • Fig. 27 Therapeutic drug monitoring testing market estimates and forecast, 2018 - 2030
  • Fig. 28 Endocrinology chemistry testing market estimates and forecast, 2018 - 2030
  • Fig. 29 Specialized chemistry testing market estimates and forecast, 2018 - 2030
  • Fig. 30 Other clinical chemistry testing market estimates and forecast, 2018 - 2030
  • Fig. 31 Medical microbiology testing market estimates and forecast, 2018 - 2030
  • Fig. 32 Infectious disease testing market estimates and forecast, 2018 - 2030
  • Fig. 33 Transplant diagnostic testing market estimates and forecast, 2018 - 2030
  • Fig. 34 Other microbiology testing market estimates and forecast, 2018 - 2030
  • Fig. 35 Hematology testing market estimates and forecast, 2018 - 2030
  • Fig. 36 Immunology testing market estimates and forecast, 2018 - 2030
  • Fig. 37 Cytology testing market estimates and forecast, 2018 - 2030
  • Fig. 38 Drug of abuse testing market estimates and forecast, 2018 - 2030
  • Fig. 39 Other esoteric tests market estimates and forecast, 2018 - 2030
  • Fig. 40 Clinical laboratory services market: Service Provider movement Analysis
  • Fig. 41 Clinical laboratory services market: Service Provider outlook and key takeaways
  • Fig. 42 Hospital-based laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 43 Stand-alone laboratories market estimates and forecasts,2018 - 2030
  • Fig. 44 Clinic-based laboratories market estimates and forecasts,2018 - 2030
  • Fig. 45 Clinical laboratory services market: application movement analysis
  • Fig. 46 Fig. .46 Clinical laboratory services market: application outlook and key takeaways
  • Fig. 47 Bioanalytical & lab chemistry services market estimates and forecasts, 2018 - 2030
  • Fig. 48 Toxicology testing services market estimates and forecasts,2018 - 2030
  • Fig. 49 Cell & gene therapy related services market estimates and forecasts, 2018 - 2030
  • Fig. 50 Preclinical & clinical trial related services market estimates and forecasts,2018 - 2030
  • Fig. 51 Drug discovery & development related services market estimates and forecasts, 2018 - 2030
  • Fig. 52 Other clinical laboratory services market estimates and forecasts,2018 - 2030
  • Fig. 53 Global clinical laboratory services market: Regional movement analysis
  • Fig. 54 Global clinical laboratory services market: Regional outlook and key takeaways
  • Fig. 55 Global clinical laboratory services market share and leading players
  • Fig. 56 North America market share and leading players
  • Fig. 57 Europe market share and leading players
  • Fig. 58 Asia Pacific market share and leading players
  • Fig. 59 Latin America market share and leading players
  • Fig. 60 Middle East & Africa market share and leading players
  • Fig. 61 North America: SWOT
  • Fig. 62 Europe SWOT
  • Fig. 63 Asia Pacific SWOT
  • Fig. 64 Latin America SWOT
  • Fig. 65 MEA SWOT
  • Fig. 66 North America
  • Fig. 67 North America market estimates and forecasts, 2018 - 2030
  • Fig. 68 U.S.
  • Fig. 69 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 70 Canada
  • Fig. 71 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 72 Europe
  • Fig. 73 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 74 UK
  • Fig. 75 UK market estimates and forecasts, 2018 - 2030
  • Fig. 76 Germany
  • Fig. 77 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 78 France
  • Fig. 79 France market estimates and forecasts, 2018 - 2030
  • Fig. 80 Italy
  • Fig. 81 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 82 Spain
  • Fig. 83 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 84 Denmark
  • Fig. 85 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 86 Sweden
  • Fig. 87 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 88 Norway
  • Fig. 89 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 90 Asia Pacific
  • Fig. 91 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 92 China
  • Fig. 93 China market estimates and forecasts, 2018 - 2030
  • Fig. 94 Japan
  • Fig. 95 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 96 India
  • Fig. 97 India market estimates and forecasts, 2018 - 2030
  • Fig. 98 Thailand
  • Fig. 99 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 100 South Korea
  • Fig. 101 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 102 Australia
  • Fig. 103 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 104 Latin America
  • Fig. 105 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 106 Brazil
  • Fig. 107 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 108 Mexico
  • Fig. 109 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 110 Colombia
  • Fig. 111 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 112 Peru
  • Fig. 113 Peru market estimates and forecasts, 2018 - 2030
  • Fig. 114 Argentina
  • Fig. 115 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 116 Middle East and Africa
  • Fig. 117 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 118 South Africa
  • Fig. 119 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 120. Saudi Arabia
  • Fig. 121 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 122UAE
  • Fig. 123 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 124 Kuwait
  • Fig. 125 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 126 Market share of key market players - Clinical laboratory services market